Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001628280-26-005474

Options or other derivatives

  • Chief Legal Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Meisner Lara Chief Legal Officer 2026-02-02 Grant or award · Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X05/wk-form4_1770240841.xml…